Hemagen Diagnostics, Inc.
HMGN · OTC
9/30/2012 | 9/30/2011 | 9/30/2010 | 9/30/2009 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $5 | $5 | $4 | $4 |
| Enterprise Value | $5 | $5 | $5 | $6 |
| Revenue | $4 | $5 | $5 | $5 |
| % Growth | -21.4% | -1.5% | -3.7% | – |
| Gross Profit | $2 | $2 | $2 | $2 |
| % Margin | 39.9% | 38.1% | 45.1% | 38.2% |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | -6.8% | -5.5% | 8.2% | -3.5% |
| Net Income | -$1 | -$1 | -$0 | -$1 |
| % Margin | -22.4% | -17.1% | -3% | -14.9% |
| EPS Diluted | -0.059 | -0.06 | -0.01 | -0.05 |
| % Growth | 2.5% | -500% | 80% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |